ACRV Acrivon Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 12, 2026
$1,99
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$1,27rendah 52m
$3,56tinggi 52m
Kapitalisasi Pasar (MRQ)
$85M
P/E
-1.0
EPS
$-2.02
lencana Anda
Rentang 52M
$1–$4
Peringkat Analis
BUY
Target Harga
$12
P/E
-1.0
ROE
-61.0%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
ACRV Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$1.99
Kapitalisasi Pasar (MRQ)
$85M
P/E
-1.0
EPS
$-2.02
ROE
-61.0%
Rentang 52M
$1–$4
ACRV Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-2.022021-12-31 → 2025-12-31
Arus Kas Bebas$-65M2022-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | ACRV | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -1.0rata-rata 5T ≈-1.8 | ≈-1.8 | · | · | |
| P/B (MRQ) | 1.0rata-rata 5T ≈1.0 | ≈1.0 | 1.7 | Kurang nilai | |
| Harga / FCF (TTM) | -1.3rata-rata 5T ≈-3.6 | ≈-3.6 | · | · | |
| Harga / Arus Kas (TTM) | -1.4rata-rata 5T ≈-3.8 | ≈-3.8 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 0.6rata-rata 5T ≈1.0 | ≈1.0 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | ACRV | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -47.8%rata-rata 5T ≈-38.8% | ≈-38.8% | -25.2% | Lemah | |
| ROE | -61.0%rata-rata 5T ≈-50.1% | ≈-50.1% | -50.0% | Di bawah rata-rata | |
| ROIC | -74.8% | · | -51.6% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | ACRV | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 8.0rata-rata 5T ≈12.1 | ≈12.1 | 5.3 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 7.6rata-rata 5T ≈11.8 | ≈11.8 | 2.7 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
11.3%
Laporan Berikutnya
Nov 11, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 19, 2026 | $-0.43 | $-0.51 | 15.7% |
| 31 Maret 2026 | Mei 20, 2026 | $-0.49 | $-0.54 | 8.6% |
| 31 Des. 2025 | $-0.52 | $-0.48 | -9.3% | |
| 30 Sep. 2025 | $-0.47 | $-0.60 | 21.9% | |
| 30 Juni 2025 | $-0.55 | $-0.60 | 8.0% | |
| 31 Maret 2025 | $-0.51 | $-0.66 | 22.1% | |
| 31 Des. 2024 | $-0.60 | $-0.68 | 11.9% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $60M | $64M | $46M | $24M | · | |
| SG&A Expense | $24M | $25M | $21M | $9M | · | |
| Operating Expenses | $84M | $89M | $67M | $33M | $16M | |
| Operating Income | $-84M | $-89M | $-67M | $-33M | $-16M | |
| Interest Income | · | · | $7M | $2M | · | |
| Other Non-op | $-270.0K | $-558.0K | $-322.0K | $1M | $21.0K | |
| Pretax Income | $-78M | $-80M | · | · | · | |
| Income Tax | $0 | · | · | · | · | |
| Net Income | $-78M | $-81M | $-60M | $-31M | $-16M | |
| EPS (Basic) | $-2.02 | $-2.38 | $-2.74 | $-7.56 | $-9.32 | |
| EPS (Diluted) | $-2.02 | $-2.38 | $-2.74 | $-7.56 | $-9.32 | |
| Shares (Basic) | 38,509,281 | 33,791,817 | 22,078,190 | 4,121,912 | 1,743,382 | |
| Shares (Diluted) | 38,509,281 | 33,791,817 | 22,078,190 | 4,121,912 | 1,743,382 | |
| EBITDA | $-84M | $-89M | $-67M | $-33M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $40M | $36M | $30M | $100M | |
| Short-term Investments | $77M | $140M | $91M | $98M | · | |
| Prepaid Expense | $2M | $2M | $2M | $4M | $805.0K | |
| Current Assets | $120M | $182M | $130M | $132M | $100M | |
| PP&E (Net) | $5M | $4M | $3M | $2M | $290.0K | |
| PP&E (Gross) | $8M | $6M | $4M | $3M | $346.0K | |
| Accum. Depreciation | $3M | $2M | $956.0K | $420.0K | $56.0K | |
| Other Non-current Assets | $2M | $2M | $251.0K | · | · | |
| Total Assets | $130M | $197M | $138M | $181M | $107M | |
| Accounts Payable | $2M | $758.0K | $5M | $904.0K | $964.0K | |
| Current Liabilities | $16M | $17M | $13M | $7M | $3M | |
| Capital Leases | $2M | $3M | $4M | $4M | $5M | |
| Total Liabilities | $17M | $20M | $17M | $11M | $8M | |
| Common Stock | $31.0K | $31.0K | $23.0K | $22.0K | $2.0K | |
| Paid-in Capital | $387M | $373M | $238M | $227M | $1M | |
| Retained Earnings | $-275M | $-197M | $-116M | $-56M | $-25M | |
| AOCI | $111.0K | $447.0K | $-83.0K | $-95.0K | · | |
| Stockholders' Equity | $113M | $177M | $121M | $170M | $-24M | |
| Liabilities + Equity | $130M | $197M | $138M | $181M | $107M | |
| Shares Outstanding | 31,648,856 | 31,231,264 | 22,522,644 | 21,920,402 | 1,769,561 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $15M | $14M | $12M | $2M | $497.0K | |
| Operating Cash Flow | $-64M | $-66M | $-43M | $-30M | $-14M | |
| CapEx | $2M | $3M | $1M | $2M | $238.0K | |
| Investing Cash Flow | $66M | $-52M | $51M | $-142M | $-238.0K | |
| Financing Cash Flow | $-749.0K | $121M | $-2M | $102M | $112M | |
| Net Change in Cash | $2M | $4M | $7M | $-70M | $98M | |
| Free Cash Flow | $-65M | $-68M | $-44M | $-32M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -47.8% | -48.1% | -37.8% | -21.7% | · | |
| ROE | -61.0% | -43.1% | -46.6% | -49.9% | · | |
| ROIC | -74.8% | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 7.7 | 10.6 | 9.7 | 20.3 | · | |
| Quick Ratio | 7.6 | 10.4 | 9.6 | 19.6 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $3.56 | $5.66 | $5.38 | $7.78 | · | |
| Cash Flow / Share | $-1.65 | $-1.94 | $-1.93 | $-7.31 | · | |
| Cash / Share | $1.31 | $1.27 | $1.60 | $1.35 | · | |
| EPS (TTM) | $-2.02 | $-2.38 | $-2.74 | $-7.56 | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-78M | $-81M | $-60M | $-31M | · | |
| Market Cap | $76M | $188M | $111M | $253M | · | |
| P/E | -1.2 | -2.5 | -1.8 | -1.5 | · | |
| P/B | 0.7 | 1.1 | 0.9 | 1.5 | · | |
| P / Tangible Book | 0.7 | 1.1 | 0.9 | 1.5 | · | |
| P / Cash Flow | -1.2 | -2.9 | -2.6 | -8.4 | · | |
| P / FCF | -1.2 | -2.7 | -2.5 | -7.8 | · | |
| Earnings Yield | -83.8% | -39.5% | -55.7% | -65.6% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $14M | $15M | $15M | $14M | $16M | $15M | $19M | $19M | $15M | $11M | $15M | $10M | $11M | $10M | · | · | |
| SG&A Expense | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | · | · | |
| Operating Expenses | $19M | $20M | $20M | $20M | $23M | $22M | $25M | $25M | $21M | $18M | $21M | $16M | $16M | $14M | $10M | $10M | |
| Operating Income | $-19M | $-20M | $-20M | $-20M | $-23M | $-22M | $-25M | $-25M | $-21M | $-18M | $-21M | $-16M | $-16M | $-14M | $-10M | $-10M | |
| Other Non-op | $-156.0K | $-129.0K | $-116.0K | $-53.0K | $-87.0K | $-14.0K | $-240.0K | $1.0K | $-55.0K | $-264.0K | $109.0K | $-97.0K | $-164.0K | $-170.0K | $1M | $377.0K | |
| Net Income | $-18M | $-19M | $-19M | $-18M | $-21M | $-20M | $-23M | $-22M | $-19M | $-16M | $-19M | $-14M | $-14M | $-13M | $-9M | $-9M | |
| EPS (Basic) | $-0.43 | $-0.49 | $-0.49 | $-0.47 | $-0.55 | $-0.51 | $-0.54 | $-0.59 | $-0.52 | $-0.73 | $-0.87 | $-0.66 | $-0.63 | $-0.58 | $4.98 | $-5.17 | |
| EPS (Diluted) | $-0.43 | $-0.49 | $-0.49 | $-0.47 | $-0.55 | $-0.51 | $-0.54 | $-0.59 | $-0.52 | $-0.73 | $-0.87 | $-0.66 | $-0.63 | $-0.58 | $4.98 | $-5.17 | |
| Shares (Basic) | 41,841,887 | 38,724,803 | · | 38,560,464 | 38,461,619 | 38,350,444 | · | 38,105,131 | 36,132,616 | 22,590,804 | · | 22,081,162 | 21,971,032 | 21,920,570 | · | 1,778,255 | |
| Shares (Diluted) | 41,841,887 | 38,724,803 | · | 38,560,464 | 38,461,619 | 38,350,444 | · | 38,105,131 | 36,132,616 | 22,590,804 | · | 22,081,162 | 21,971,032 | 21,920,570 | · | 1,778,255 | |
| EBITDA | $-19M | $-20M | · | $-20M | $-23M | $-22M | · | $-25M | $-21M | $-18M | · | $-16M | $-16M | $-14M | · | $-10M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $34M | $41M | $35M | $42M | $39M | $40M | $43M | $46M | $25M | $36M | $30M | $38M | $27M | $30M | $32M | |
| Short-term Investments | $49M | $64M | $77M | $94M | $96M | $110M | $140M | $144M | $135M | $85M | $91M | $112M | $113M | $93M | $98M | · | |
| Prepaid Expense | $2M | $1M | $2M | $1M | $989.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $4M | $2M | |
| Current Assets | $91M | $99M | $120M | $130M | $138M | $151M | $182M | $189M | $182M | $112M | $130M | $144M | $153M | $124M | $132M | $79M | |
| PP&E (Net) | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $5M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $8M | $8M | $8M | $8M | $8M | $7M | $6M | $6M | $5M | $5M | $4M | $3M | $3M | $3M | $3M | $2M | |
| Accum. Depreciation | $4M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $1M | $956.0K | $807.0K | $674.0K | $545.0K | $420.0K | $295.0K | |
| Other Non-current Assets | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | · | · | $251.0K | · | · | · | · | · | |
| Total Assets | $99M | $108M | $130M | $145M | $159M | $176M | $197M | $215M | $231M | $121M | $138M | $151M | $160M | $170M | $181M | $88M | |
| Accounts Payable | $861.0K | $1M | $2M | $996.0K | $1M | $4M | $758.0K | $2M | $1M | $2M | $5M | $2M | $1M | $1M | $904.0K | $2M | |
| Current Liabilities | $11M | $11M | $16M | $15M | $13M | $14M | $17M | $15M | $11M | $9M | $13M | $9M | $7M | $6M | $7M | $6M | |
| Capital Leases | $980.0K | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Total Liabilities | $12M | $12M | $17M | $17M | $16M | $16M | $20M | $18M | $15M | $13M | $17M | $13M | $11M | $10M | $11M | $11M | |
| Common Stock | $42.0K | $38.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $23.0K | $23.0K | $22.0K | $22.0K | $22.0K | $22.0K | $2.0K | |
| Paid-in Capital | $399M | $389M | $387M | $384M | $381M | $377M | $373M | $370M | $368M | $241M | $238M | $236M | $232M | $229M | $227M | $2M | |
| Retained Earnings | $-312M | $-294M | $-275M | $-256M | $-238M | $-217M | $-197M | $-174M | $-152M | $-133M | $-116M | $-97M | $-83M | $-69M | $-56M | $-47M | |
| AOCI | $-33.0K | $4.0K | $111.0K | $112.0K | $106.0K | $283.0K | $447.0K | $782.0K | $-19.0K | $-70.0K | $-83.0K | $-302.0K | $-427.0K | $9.0K | $-95.0K | $-133.0K | |
| Stockholders' Equity | $87M | $96M | $113M | $129M | $143M | $160M | $177M | $197M | $216M | $108M | $121M | $138M | $149M | $160M | $170M | $-46M | |
| Liabilities + Equity | $99M | $108M | $130M | $145M | $159M | $176M | $197M | $215M | $231M | $121M | $138M | $151M | $160M | $170M | $181M | $88M | |
| Shares Outstanding | 42,847,215 | 38,745,032 | 31,648,856 | 31,549,770 | 31,449,744 | 31,352,067 | 31,231,264 | 31,130,892 | 30,966,255 | 22,637,539 | 22,522,644 | 22,104,469 | 22,068,660 | 21,920,634 | 21,920,402 | 1,794,600 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $267.0K | |
| Operating Cash Flow | $-15M | $-21M | $-15M | $-12M | $-17M | $-20M | $-17M | $-17M | $-14M | $-17M | $-12M | $-10M | $-9M | $-11M | $-9M | $-7M | |
| CapEx | $87.0K | $14.0K | $219.0K | $899.0K | $493.0K | $58.0K | $827.0K | $989.0K | $137.0K | $815.0K | $1M | $0 | $112.0K | $25.0K | $251.0K | $426.0K | |
| Investing Cash Flow | $15M | $13M | $22M | $6M | $19M | $19M | $14M | $16M | $-88M | $6M | $21M | $2M | $19M | $9M | $-95M | $-45M | |
| Financing Cash Flow | $7M | $-33.0K | $-192.0K | $-117.0K | $-97.0K | $-343.0K | $-647.0K | $-2M | $123M | $-172.0K | $-2M | $78.0K | · | · | $102M | $-140.0K | |
| Net Change in Cash | $7M | $-7M | $6M | $-6M | $3M | $-664.0K | $-4M | $-3M | $21M | $-11M | $6M | $-8M | $11M | $-2M | $-3M | $-52M | |
| Free Cash Flow | · | $-21M | · | · | · | $-20M | · | · | · | $-18M | · | · | · | $-11M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -13.9% | -13.4% | · | -10.1% | -10.8% | -13.3% | · | -12.3% | -9.6% | -11.3% | · | -12.1% | -17.4% | -15.0% | · | -21.0% | |
| ROE | -15.6% | -14.9% | · | -11.2% | -11.7% | -14.7% | · | -13.4% | -10.3% | -12.3% | · | -31.3% | -18.6% | -15.9% | · | 40.3% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 9.0 | · | 8.8 | 10.3 | 11.2 | · | 12.8 | 16.2 | 12.4 | · | 15.5 | 21.8 | 21.8 | · | 12.3 | |
| Quick Ratio | 7.9 | 8.8 | · | 8.7 | 10.2 | 11.0 | · | 12.6 | 16.0 | 12.2 | · | 15.3 | 21.5 | 21.2 | · | 5.0 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.02 | $2.47 | · | $4.08 | $4.55 | $5.12 | · | $6.32 | $6.98 | $4.77 | · | $6.25 | $6.76 | $7.32 | · | $-25.42 | |
| Cash Flow / Share | · | $-0.53 | · | · | · | $-0.51 | · | · | · | $-0.76 | · | · | · | $-0.52 | · | · | |
| Cash / Share | $0.97 | $0.88 | · | $1.12 | $1.33 | $1.25 | · | $1.39 | $1.49 | $1.09 | · | $1.35 | $1.73 | $1.25 | · | $17.88 | |
| EPS (TTM) | $-1.88 | $-2.00 | · | $-2.07 | $-2.19 | $-2.16 | · | $-2.71 | $-2.78 | $-2.89 | · | $3.11 | $-1.40 | $-4.06 | · | $-15.00 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-74M | $-77M | · | $-82M | $-86M | $-84M | · | $-77M | $-69M | $-64M | · | $-50M | $-45M | $-37M | · | $-27M | |
| Market Cap | $76M | $54M | · | $57M | $37M | $64M | · | $218M | $180M | $162M | · | $211M | $286M | $278M | · | · | |
| P/E | -0.9 | -0.7 | · | -0.9 | -0.5 | -0.9 | · | -2.6 | -2.1 | -2.5 | · | 3.1 | -9.3 | -3.1 | · | · | |
| P/B | 0.9 | 0.6 | · | 0.4 | 0.3 | 0.4 | · | 1.1 | 0.8 | 1.5 | · | 1.5 | 1.9 | 1.7 | · | · | |
| P / Tangible Book | 0.9 | 0.6 | · | 0.4 | 0.3 | 0.4 | · | 1.1 | 0.8 | 1.5 | · | 1.5 | 1.9 | 1.7 | · | · | |
| P / Cash Flow | · | -2.6 | · | · | · | -3.3 | · | · | · | -9.5 | · | · | · | -24.5 | · | · | |
| Earnings Yield | -105.6% | -143.9% | · | -114.4% | -184.0% | -106.4% | · | -38.7% | -47.9% | -40.4% | · | 32.5% | -10.8% | -32.0% | · | · |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-78M | $-81M | $-60M | $-31M | $-16M |
| EPS Dilusian | $-2.02 | $-2.38 | $-2.74 | $-7.56 | $-9.32 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 7.7 | 10.6 | 9.7 | 20.3 | · |
| Rasio Cepat | 7.6 | 10.4 | 9.6 | 19.6 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-65M | $-68M | $-44M | $-32M | · |
Pemilik institusional (13F) 48 pengaju · $38.1M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
48
Nilai yang dipegang
$38.1M
Posisi baru
6
Posisi yang keluar
4
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 6 (-4 vs Kuartal sebelumnya) | 4 (-8 vs Kuartal sebelumnya) | 21 (+10 vs Kuartal sebelumnya) | 9 (-2 vs Kuartal sebelumnya) | +5.2M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $21.768.325 | 12.229.396 | 57,08% | Saham |
| Sands Capital Alternatives, LLC | $4.074.902 | 2.289.271 | 10,68% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.694.574 | 952.008 | 4,44% | Saham |
| VANGUARD GROUP INC | $1.684.246 | 698.857 | 4,42% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $1.580.871 | 888.130 | 4,15% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $1.350.776 | 758.863 | 3,54% | Saham |
| TWO SIGMA INVESTMENTS, LP | $1.141.866 | 641.498 | 2,99% | Saham |
| MARSHALL WACE, LLP | $946.704 | 531.856 | 2,48% | Saham |
| TWO SIGMA ADVISERS, LP | $804.393 | 333.773 | 2,11% | Saham |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $674.442 | 378.900 | 1,77% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $472.273 | 265.241 | 1,24% | Saham |
| BlackRock, Inc. | $425.620 | 239.112 | 1,12% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $327.748 | 184.128 | 0,86% | Saham |
| XTX Topco Ltd | $317.265 | 178.239 | 0,83% | Saham |
| JANE STREET GROUP, LLC | $132.874 | 74.648 | 0,35% | Saham |
| NORTHERN TRUST CORP | $119.620 | 67.202 | 0,31% | Saham |
| STATE STREET CORP | $119.518 | 67.145 | 0,31% | Saham |
| UBS Group AG | $78.053 | 43.850 | 0,20% | Saham |
| CITADEL ADVISORS LLC | $73.471 | 41.276 | 0,19% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $52.212 | 29.332 | 0,14% | Saham |
| Spark Investment Management LLC | $50.374 | 28.300 | 0,13% | Saham |
| PRELUDE CAPITAL MANAGEMENT, LLC | $42.747 | 24.015 | 0,11% | Saham |
| BANK OF AMERICA CORP /DE/ | $29.204 | 16.407 | 0,08% | Saham |
| Verdad Advisers, LP | $26.796 | 15.054 | 0,07% | Saham |
| GOLDMAN SACHS GROUP INC | $26.558 | 14.920 | 0,07% | Saham |
| Squarepoint Ops LLC | $23.690 | 13.309 | 0,06% | Saham |
| AAF Wealth Management, LLC | $19.007 | 10.678 | 0,05% | Saham |
| Marex Group Ltd | $17.800 | 10.000 | 0,05% | Saham |
| FEDERATED HERMES, INC. | $14.105 | 7.924 | 0,04% | Saham |
| BARCLAYS PLC | $13.090 | 7.354 | 0,03% | Saham |
| FMR LLC | $12.383 | 6.957 | 0,03% | Saham |
| MORGAN STANLEY | $9.315 | 5.233 | 0,02% | Saham |
| Tower Research Capital LLC (TRC) | $2.985 | 1.677 | 0,01% | Saham |
| ACADIAN ASSET MANAGEMENT LLC | $2.073 | 1.165.119 | 0,01% | Saham |
| Crews Bank & Trust | $1.858 | 1.044 | 0,00% | Saham |
| JPMORGAN CHASE & CO | $1.337 | 751 | 0,00% | Saham |
| NISA INVESTMENT ADVISORS, LLC | $1.040 | 584 | 0,00% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $956 | 537 | 0,00% | Saham |
| Redwood Park Advisors LLC | $890 | 500 | 0,00% | Saham |
| Russell Investments Group, Ltd. | $856 | 481 | 0,00% | Saham |
| Federation des caisses Desjardins du Quebec | $712 | 400 | 0,00% | Saham |
| Steward Partners Investment Advisory, LLC | $580 | 326 | 0,00% | Saham |
| GSA CAPITAL PARTNERS LLP | $357 | 200.415 | 0,00% | Saham |
| SBI Securities Co., Ltd. | $134 | 75 | 0,00% | Saham |
| Caitong International Asset Management Co., Ltd | $89 | 50 | 0,00% | Saham |
| HRT FINANCIAL LP | $18 | 10.316 | 0,00% | Saham |
| CITIGROUP INC | $11 | 6 | 0,00% | Saham |
| ROYAL BANK OF CANADA | $0 | 30 | 0,00% | Saham |
Aktivis & pemilik 5%+ 1 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 pengajuan | 23 April 2026 | 28,80% | Amandemen | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 18 orang dalam · 10 pejabat · 8 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Peter Blume-Jensen | President and CEO | 14 Agu 2024 F | 2.502.129 | 0 | 0 | $0 |
| Rasmus Holm-Jorgensen | Chief Financial Officer | 1 Maret 2025 A | 26.088 | 0 | 0 | $0 |
| Eric Devroe | Chief Operating Officer | 18 Agu 2026 S | 146.349 | 1 | 1 | $15.986 |
| Michaela Levin | Chief Business Officer | 31 Agu 2026 A | 30.000 | 0 | 0 | $0 |
| Katharine Peterson | Chief Accounting Officer | 18 Agu 2026 S | 18.033 | 0 | 1 | $-203 |
| Erick Gamelin | Chief Development Officer | 18 Agu 2026 S | 52.592 | 0 | 1 | $-804 |
| Mary Miller | Chief Legal Officer | 18 Agu 2026 S | 82.009 | 0 | 2 | $-1.380 |
| Mansoor Raza Mirza | Chief Medical Officer | 18 Mei 2026 A | 38.817 | 0 | 0 | $0 |
| Jean-Marie Cuillerot | Chief Medical Officer | 1 Maret 2025 A | · | 0 | 0 | $0 |
| Kristina Masson | EVP - Business Operations | 14 Agu 2024 F | 317.246 | 0 | 0 | $0 |
| Santhosh Palani | Direktur | 17 Juni 2026 A | 9.366 | 0 | 0 | $0 |
| Derek Dirocco | Direktur | 17 Juni 2026 A | 9.366 | 0 | 0 | $0 |
| Sharon Shacham | Direktur | 17 Juni 2026 A | 9.366 | 0 | 0 | $0 |
| Charles M Baum | Direktur | 17 Juni 2026 A | 9.366 | 0 | 0 | $0 |
| Michael John Tomsicek | Direktur | 17 Juni 2026 A | 9.366 | 0 | 0 | $0 |
| Ivana Magovcevic-Liebisch | Direktur | 17 Juni 2026 A | 9.366 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Pemilik 10% | 17 Nov. 2022 C | 888.130 | 0 | 0 | $0 |
| Adam D. Levy | · | 4 Agu 2026 S | 66.008 | 1 | 1 | $13.221 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 3 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
ACRV Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 13 analis
BELI
Target median
$10.50
+427,6%
4 30,8%
Beli Kuat
8 61,5%
Beli
1 7,7%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
6 analis · 2026-10-03Target rata-rata $11.50 +477,9%
← Di bawah semua target
Harga saat ini $1.99
Rendah$7.00
Rata-rata$11.50
Tinggi$19.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| ACRV | $76M | -1.2 | · | · | -61.0% | · |
| CTOR | $170M | -6.0 | · | · | -61.5% | · |
| CNXU | · | · | · | · | · | · |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | · |
| MNOV | $64M | -5.5 | · | -2928.8% | -27.1% | · |
| ICCC | · | -51.2 | 4.3% | · | · | · |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | · |
| SERA | · | -4.4 | 5.2% | -39417.3% | -39.0% | · |
| GRML | · | · | · | · | -104.9% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 12, 2026